Table of Content

Executive Dashboard
Purpose of this Experiential Study
5-Step Process to Transformational Growth
Market Engineering Measurements
Scope and Segmentation
Key Questions to be Answered

Growth Environment
China’s Pharmaceutical Industry—Market Overview
Leading Trends Driving the Chinese Pharmaceutical Industry
Drivers and Restraints
Reforms Leading to Transformation in the Industry
Reforms Leading to Transformation in the Industry (continued)
Transitioning Reimbursement Landscape
Shift towards a Commercial Insurance Model
Changing Dynamics of Distributor Networks

Market Forecasts
Market Engineering Measurements
Forecast Assumptions
Revenue Forecast—Total Pharmaceutical Market
Revenue Forecast—By Segments
Revenue Forecast Discussion
Market Share Analysis
Revenue Forecast—Small Molecule
Revenue Forecast—Biologics Segment
Revenue Forecast—Therapeutic Biologics by Segments
Revenue Forecast Discussion by Segments
Biologics Pipeline in Collaboration with Biopharma

Vision and Strategy—Growth Opportunities
Pharmaceutical Commercial Landscape
4 Major Growth Opportunities
Growth Opportunity 1—Intermediates and Fine Chemicals for Pharma Manufacturing
Growth Opportunity 2—Innovative Biologic Pipeline Bridging the Gap with Regulated Markets
Bridging the Gap with Regulated Markets
Growth Opportunity 3—Thriving CDMO Industry Attracting Pharma Investments
Measures Taken by CDMO/CRO Participants to Attract Investments
Growth Opportunity 4—Biosimilar Co-Development for Oncology
Policy Changes to Support Biosimilar Development
Strategic Imperatives for Growth

The Last Word
Conclusion
Legal Disclaimer

Appendix
List of Exhibits